Nutriband Inc (NTRB) Stock Price, Quote & News

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

Covode13 Apr. 23 at 12:01 PM

$NTRB we keep talking about the drug problem. But are we ever going to file for FDA approval!?

1 · Reply

nutriband_com Apr. 22 at 7:29 PM

$NTRB $NTRBW Nutriband CEO Gareth Sheridan discussed the opioid crisis and AVERSA™ technology on the latest Jack Neel Podcast. Company strategy and transdermal drug delivery focus highlighted. https://www.nutriband.com/post/nutriband-ceo-gareth-sheridan-discusses-the-us-fentanyl-crisis-and-company-update-on-latest-episode #NTRB #biotech #healthcare #pharma

0 · Reply

NetworkNewsWire Apr. 22 at 6:18 PM

BioMedNewsBreaks — $NTRB CEO Highlights AVERSA Technology on Jack Neel Podcast https://ibn.fm/fSUKj

0 · Reply

DisneyPalaceTrades Apr. 22 at 3:44 AM

$NTRB on my list

0 · Reply

JhonHack Apr. 22 at 3:19 AM

$NTRB zzzzzzzzzzzz

0 · Reply

birdmanCap Apr. 17 at 6:39 PM

$NTRB here we go

0 · Reply

NNTrader Apr. 17 at 5:54 PM

$NTRB any news?

0 · Reply

birdmanCap Apr. 16 at 2:04 PM

$NTRB signals

0 · Reply

birdmanCap Apr. 8 at 5:30 PM

$NTRB another run up looks like it’s forming

0 · Reply

birdmanCap Apr. 7 at 2:17 AM

$NTRB $15 price target 👀

0 · Reply

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

NTRBW

Mar 30, 2026, 4:05 PM EDT - 26 days ago

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

Feb 17, 2026, 7:28 AM EST - 2 months ago

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

NTRBW

Jan 30, 2026, 7:00 AM EST - 3 months ago

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

NTRBW

Dec 31, 2025, 7:00 AM EST - 4 months ago

Nutriband CEO Publishes Letter to Shareholders

NTRBW

Dec 29, 2025, 9:00 AM EST - 4 months ago

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

NTRBW

Dec 18, 2025, 7:00 AM EST - 4 months ago

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

NTRBW

Nov 24, 2025, 7:00 AM EST - 5 months ago

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

NTRBW

Oct 28, 2025, 11:05 AM EDT - 6 months ago

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

Oct 28, 2025, 7:00 AM EDT - 6 months ago

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

NTRBW

Oct 10, 2025, 7:00 AM EDT - 7 months ago

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

NTRBW

Oct 8, 2025, 8:30 AM EDT - 7 months ago

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

NTRBW

Oct 8, 2025, 6:30 AM EDT - 7 months ago

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

NTRBW

Sep 24, 2025, 4:05 PM EDT - 7 months ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

NTRBW

Sep 10, 2025, 9:15 AM EDT - 8 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

NTRBW

Sep 3, 2025, 4:01 PM EDT - 8 months ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

NTRBW

Aug 18, 2025, 9:00 AM EDT - 8 months ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Aug 11, 2025, 5:00 AM EDT - 9 months ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

NTRBW

Aug 8, 2025, 8:00 AM EDT - 9 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Jul 18, 2025, 9:15 AM EDT - 10 months ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

NTRBW

Jul 2, 2025, 8:05 AM EDT - 10 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

NTRBW

Jul 1, 2025, 7:00 AM EDT - 10 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

NTRBW

Jun 9, 2025, 7:30 AM EDT - 11 months ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

NTRBW

Apr 11, 2025, 7:00 AM EDT - 1 year ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

NTRBW

Apr 4, 2025, 5:41 PM EDT - 1 year ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

NTRBW

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Nutriband Signs Partnership Agreement with Charlotte FC

NTRBW

Feb 21, 2025, 7:00 AM EST - 1 year ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

NTRBW

Feb 13, 2025, 7:00 AM EST - 1 year ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

NTRBW

Feb 7, 2025, 8:45 AM EST - 1 year ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

NTRBW

Dec 31, 2024, 7:00 AM EST - 1 year ago

Nutriband Issues Letter to Shareholders

NTRBW

Dec 27, 2024, 9:25 AM EST - 1 year ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

NTRBW

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Nov 27, 2024, 7:00 AM EST - 1 year ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

NTRBW

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

NTRBW

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

NTRBW

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

NTRBW

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

NTRBW

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

NTRBW

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

NTRBW

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRBW

Jul 19, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

NTRBW

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

NTRBW

Jun 20, 2024, 7:00 AM EDT - 2 years ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

NTRBW

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

NTRBW

May 16, 2024, 7:00 AM EDT - 2 years ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

NTRBW

May 10, 2024, 9:00 AM EDT - 2 years ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CANF

Apr 23, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

NTRBW

Apr 19, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Announces $8.4M Private Placement

NTRBW

Mar 25, 2024, 7:00 AM EDT - 2 years ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Mar 4, 2024, 7:00 AM EST - 2 years ago

Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting

NTRBW

Covode13 Apr. 23 at 12:01 PM

$NTRB we keep talking about the drug problem. But are we ever going to file for FDA approval!?

1 · Reply

nutriband_com Apr. 22 at 7:29 PM

0 · Reply

NetworkNewsWire Apr. 22 at 6:18 PM

BioMedNewsBreaks — $NTRB CEO Highlights AVERSA Technology on Jack Neel Podcast https://ibn.fm/fSUKj

0 · Reply

DisneyPalaceTrades Apr. 22 at 3:44 AM

$NTRB on my list

0 · Reply

JhonHack Apr. 22 at 3:19 AM

$NTRB zzzzzzzzzzzz

0 · Reply

birdmanCap Apr. 17 at 6:39 PM

$NTRB here we go

0 · Reply

NNTrader Apr. 17 at 5:54 PM

$NTRB any news?

0 · Reply

birdmanCap Apr. 16 at 2:04 PM

$NTRB signals

0 · Reply

birdmanCap Apr. 8 at 5:30 PM

$NTRB another run up looks like it’s forming

0 · Reply

birdmanCap Apr. 7 at 2:17 AM

$NTRB $15 price target 👀

0 · Reply

Channelchek Apr. 6 at 8:00 PM

Noble Capital Markets Research Report: Nutriband ($NTRB ) - First Marketing Partnership Expands Territory and Brings A Product Approval Marketing Partnership Covering Costa Rica Brings First Success. In February, Nutriband signed an agreement with Costa Rica’s Innomedica CCB, making it the territory’s exclusive distributor of Nutriband products and AVERSA Fentanyl upon approval. Shortly afterward, the Costa Rican Ministry of Health approved the Nutriband kinesiology tapes for import and sale, making them the first Nutriband products that Innomedica has guided through local regulatory approvals. It plans to begin marketing efforts for the kinesiology tapes, the mosquito repellent patch, and begin AVERSA Fentanyl patch marketing in anticipation of approval. Read the full report here: https://www.channelchek.com/news-channel/nutriband-ntrb-first-marketing-partnership-expands-territory-and-brings-a-product-approval

0 · Reply

BGfalcons Apr. 1 at 11:25 PM

$NTRB They have been beating this same drum for the last 3 years with no product yet to market for the patch. No wonder this share price is not moving.

2 · Reply

birdmanCap Apr. 1 at 4:39 PM

$NTRB looks like any selling has dried up Any spark here and this runs

0 · Reply

NetworkNewsWire Mar. 31 at 6:22 PM

BioMedNewsBreaks – $NTRB Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch https://ibn.fm/RA8fA

0 · Reply

Acousticstyle Mar. 31 at 1:51 PM

$NTRB https://finance.yahoo.com/sectors/healthcare/articles/nutriband-selects-commercial-brand-name-200500216.html

0 · Reply

nutriband_com Mar. 31 at 9:46 AM

$NTRB Nutriband Inc. selected a commercial brand name candidate for its abuse-deterrent fentanyl transdermal system (AVERSA™). Next step includes submission to FDA and international regulators for review. Full details 👉 https://www.nutriband.com/post/nutriband-selects-commercial-brand-name-for-its-abuse-deterrent-fentanyl-patch #NTRB #biotech #pharma #healthcare #drugdelivery

0 · Reply

RiccoTheGreat2 Mar. 30 at 8:09 PM

$NTRB I’ve been following this company for far too long. What a fucking hunk of shit. Still have my shares now they’re red what’s wrong with this management? pull your heads out of your asses !!

0 · Reply

longtime Mar. 26 at 3:34 PM

$NTRB too quiet. This usually has a weird pop. I bought in at these prices. Worth a shot.

2 · Reply

nutriband_com Mar. 20 at 5:18 PM

$NTRB Nasdaq congratulated Nutriband on approval to enter the Costa Rica market with its AI Kinesiology Tape product line. Approval allows distribution through partner Innomedica and supports international expansion. #NTRB #biotech #pharma #nasdaq #healthcare #medtech

0 · Reply

OfficialStocktwitsUser Mar. 18 at 10:25 PM

$NTRB RSI: 37.16, MACD: -0.1466 Vol: 0.24, MA20: 4.16, MA50: 4.32 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

nutriband_com Mar. 18 at 4:46 PM

$NTRB Nutriband Inc. announced approval from the Costa Rica Ministry of Health for its AI Kinesiology Tape line. The company plans to expand commercialization in the region with its distribution partner. Full details 👉 https://www.nutriband.com/post/nutriband-ai-kinesiology-tapes-approved-for-distribution-and-sale-in-costa-rica #NTRB #Nutriband #Healthcare #Biotech #MarketUpdate #InvestorNews

0 · Reply

NetworkNewsWire Mar. 18 at 2:52 PM

BioMedNewsBreaks — $NTRB Secures Costa Rica Approval for Kinesiology Tape Line https://ibn.fm/LmF4t

0 · Reply

Market Cap	48.82M
Revenue (ttm)	2.14M
Net Income (ttm)	-10.48M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	2.88
Profit Margin	-489.72%
Debt to Equity Ratio	0.01

Volume	3,600
Avg Vol	10,844
Day's Range	N/A - N/A
Shares Out	12.18M
Stochastic %K	40%
Beta	1.92
Analysts	Sell
Price Target	$15.00